These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 23427056

  • 1. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.
    Ma X, Meng J, Jia M, Bi L, Zhou Y, Wang Y, Hu J, He G, Luo X.
    J Bone Miner Res; 2013 Jul; 28(7):1641-52. PubMed ID: 23427056
    [Abstract] [Full Text] [Related]

  • 2. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats.
    Zhang R, Hu SJ, Li C, Zhang F, Gan HQ, Mei QB.
    J Ethnopharmacol; 2012 Jan 06; 139(1):12-8. PubMed ID: 21669273
    [Abstract] [Full Text] [Related]

  • 3. Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats.
    Sung MJ, Davaatseren M, Hur HJ, Kim HJ, Ryu SY, Choi YH, Cha MR, Kwon DY.
    Phytother Res; 2012 Aug 06; 26(8):1182-8. PubMed ID: 22821855
    [Abstract] [Full Text] [Related]

  • 4. Formononetin reverses established osteopenia in adult ovariectomized rats.
    Tyagi AM, Srivastava K, Singh AK, Kumar A, Changkija B, Pandey R, Lahiri S, Nagar GK, Yadav DK, Maurya R, Trivedi R, Singh D.
    Menopause; 2012 Aug 06; 19(8):856-63. PubMed ID: 22781783
    [Abstract] [Full Text] [Related]

  • 5. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
    Han X, Xu Y, Wang J, Pei X, Yang R, Li N, Li Y.
    Bone; 2009 May 06; 44(5):942-7. PubMed ID: 19124090
    [Abstract] [Full Text] [Related]

  • 6. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.
    Zheng H, Qi S, Chen C.
    Molecules; 2018 Sep 19; 23(9):. PubMed ID: 30235836
    [Abstract] [Full Text] [Related]

  • 7. GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia.
    Nuche-Berenguer B, Lozano D, Gutiérrez-Rojas I, Moreno P, Mariñoso ML, Esbrit P, Villanueva-Peñacarrillo ML.
    J Endocrinol; 2011 May 19; 209(2):203-10. PubMed ID: 21372151
    [Abstract] [Full Text] [Related]

  • 8. Glucagon like peptide 2 has a positive impact on osteoporosis in ovariectomized rats.
    Xu B, He Y, Lu Y, Ren W, Shen J, Wu K, Xu K, Wu J, Hu Y.
    Life Sci; 2019 Jun 01; 226():47-56. PubMed ID: 30959027
    [Abstract] [Full Text] [Related]

  • 9. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
    Rissanen JP, Suominen MI, Peng Z, Morko J, Rasi S, Risteli J, Halleen JM.
    Calcif Tissue Int; 2008 Feb 01; 82(2):155-61. PubMed ID: 18219436
    [Abstract] [Full Text] [Related]

  • 10. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY, Lee SK, Jo KJ, Song DY, Lim DM, Park KY, Bonewald LF, Kim BJ.
    Life Sci; 2013 Mar 21; 92(10):533-40. PubMed ID: 23357248
    [Abstract] [Full Text] [Related]

  • 11. A traditional Chinese herbal preparation, Er-Zhi-Wan, prevent ovariectomy-induced osteoporosis in rats.
    Cheng M, Wang Q, Fan Y, Liu X, Wang L, Xie R, Ho CC, Sun W.
    J Ethnopharmacol; 2011 Nov 18; 138(2):279-85. PubMed ID: 22001072
    [Abstract] [Full Text] [Related]

  • 12. Combined oral administration of bovine collagen peptides with calcium citrate inhibits bone loss in ovariectomized rats.
    Liu J, Wang Y, Song S, Wang X, Qin Y, Si S, Guo Y.
    PLoS One; 2015 Nov 18; 10(8):e0135019. PubMed ID: 26258559
    [Abstract] [Full Text] [Related]

  • 13. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 18; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

  • 14. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 18; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 15. Role of gastrointestinal hormones in postprandial reduction of bone resorption.
    Henriksen DB, Alexandersen P, Bjarnason NH, Vilsbøll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C.
    J Bone Miner Res; 2003 Dec 18; 18(12):2180-9. PubMed ID: 14672353
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE, Stavropoulou A, Anastassopoulos G, Panteliou SD, Papadaki E, Karamanos NK, Panagiotopoulos E.
    J Pharm Biomed Anal; 2006 Jun 07; 41(3):891-7. PubMed ID: 16488571
    [Abstract] [Full Text] [Related]

  • 17. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.
    J Bone Miner Res; 2007 Jun 07; 22(6):849-59. PubMed ID: 17352644
    [Abstract] [Full Text] [Related]

  • 18. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA, Hegazy S, El-Desoky K.
    Phytomedicine; 2010 Feb 07; 17(2):116-25. PubMed ID: 19577454
    [Abstract] [Full Text] [Related]

  • 19. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
    Ederveen AG, Spanjers CP, Quaijtaal JH, Kloosterboer HJ.
    J Bone Miner Res; 2001 Sep 07; 16(9):1674-81. PubMed ID: 11547837
    [Abstract] [Full Text] [Related]

  • 20. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun 07; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.